UNSPSC 41202041: Mumps virus serological reagents

In this classification, Mumps virus serological reagents are devices used in test to identify specific Mumps virus antibodies in serum. US FDA regulates Mumps virus serological reagents under 21 CFR 866.3380 and under FDA product code GRC.

UNSPSC 41202041 Mumps virus serological reagents is a Commodity code that in recent state and local procurement actually tracks HIV and Syphilis testing supplies, reagents, and related diagnostic services rather than mumps-specific serology. State and local health departments, criminal justice agencies, and public universities are soliciting under this code for blood screening reagents, immunoassay kits, control solutions, calibrators, and automated or semi-automated testing platforms to support disease surveillance, public health programs, and forensic laboratory operations. The Illinois Department of Public Health has posted multiple procurements for HIV and Syphilis reagents and instrumentation; Collin County (Texas) Community Supervision and Corrections Department is soliciting offender drug and specimen testing services that include immunoassay screening with confirmatory testing; the City of Austin is seeking rapid HIV test kits for the Austin Public Health Program; and the University of Houston has issued an RFP for blood chemistry reagents and diagnostic testing services. These solicitations span testing volumes from approximately 375 to 25,000+ annual tests depending on the use case.

Recent activity concentrates in Texas and Illinois. The most substantial current opportunity is Collin County's RFP 2026-327 for offender specimen collection and drug testing services (response due July 23, 2026), valued at approximately $600,000 over two years with optional three one-year renewals, requiring SAMHSA-, Texas DPS-, or CAP-certified lab operations and staffing two collection sites with immunoassay screening and LC/MS/MS or GC/MS confirmation across approximately 25,000 annual tests on a per-test pricing model. The Illinois Department of Public Health issued an IFB (due March 16, 2026) for a five-year Hepatitis/HIV/Syphilis combination screening instrument and reagent contract in Jackson County with estimated annual volumes of 13,200 HIV tests and 11,000 Syphilis tests, requiring fully automated single-instrument testing capability and no equipment cost to the state. The City of Austin's IFB (due July 17, 2026) seeks Abbott Determine HIV 1/2 test kits and controls for the public health program on an all-inclusive pricing basis. The Illinois Department of Public Health also executed an emergency sole-source contract with Abbott Laboratories Inc. for HIV/Syphilis reagents and maintenance services valued at $38,079.50 to maintain operations at its Carbondale Laboratory. The code shows limited geographic spread beyond Texas and Illinois with no recent activity detected in other states.